Authors: SIBILLE M DEIGAT N JANIN A KIRKESSELI S DURAND DV

Citation: M. Sibille et al., ADVERSE EVENTS IN PHASE-I STUDIES - A REPORT IN 1015 HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 54(1), 1998, pp. 13-20

Authors: PATAT A KIRKESSELI S LEFEBVRE P CALIC F MONTAY G LECOZ F GANDON JM

Citation: A. Patat et al., RILUZOLE SINGLE-DOSE PHARMACOKINETICS IN PATIENTS WITH IMPAIRED LIVER-FUNCTION, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 64-64

Authors: LELIBOUX A LEFEBVRE P LEROUX Y TRUFFINET P AUBENEAU M KIRKESSELI S MONTAY G

Citation: A. Leliboux et al., SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF RILUZOLE IN WHITE SUBJECTS, Journal of clinical pharmacology, 37(9), 1997, pp. 820-827

Authors: HUMBERT H CABIAC MD DENOUEL J KIRKESSELI S

Citation: H. Humbert et al., PHARMACOKINETICS OF TERBINAFINE AND OF ITS 5 MAIN METABOLITES IN PLASMA AND URINE, FOLLOWING A SINGLE ORAL DOSE IN HEALTHY-SUBJECTS, Biopharmaceutics & drug disposition, 16(8), 1995, pp. 685-694